In a Neutral regime, XBI's AIQ Score of 54/100 with Quality base of 61/100 and stable Momentum at 43/100 signals mixed conviction. Wait for component alignment before adding exposure. Watch momentum trend for confirmation or fading.
Quality (61/100) leads while Momentum (43/100) lags. This cross-factor spread creates entry timing uncertainty. Wait for the lagging factor to begin recovering before adding aggressively.
Quick Stats
XBI's recent component-level deltas are not available in this snapshot. Use the current AIQ, Sharpe, and volatility profile above as the primary read until the next data refresh.
Snapshot: 2026-07-28T04:58:53.297Z.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AI Analysis Report
Scenario Analysis
AIQ Scenario Builder
State Street SPDR S&P Biotech ETF (XBI) Stock Analysis
State Street SPDR S&P Biotech ETF (XBI) has an AIQ Score of 54/100 in a Neutral regime as of Jul 28, 2026. Quality is strongest at 61/100. Momentum is weakest at 43/100. The main conflict is that quality leads at 61/100 while momentum lags at 43/100.
State Street SPDR S&P Biotech ETF (XBI) carries an AIQ Score of 54 out of 100, placing it in a mixed signal regime for this snapshot. A mid-range reading typically means component signals are not fully aligned, so interpretation should focus on what is improving versus what is lagging.
Beta is 1.10, implying roughly 10% higher sensitivity than a broad market baseline. Sharpe ratio is 1.99 (strong), which frames recent return efficiency versus risk.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | XBI is in a Neutral AIQ regime with score 54/100. |
| Signal Conflict | The primary conflict is that quality leads at 61/100 while momentum lags at 43/100. |
| Factor Evidence | Momentum 43/100 · Quality 61/100 · Risk 59/100 |
| Persistence | Score-history persistence is not available for this symbol yet. |
| Checklist | Status | Evidence |
|---|---|---|
| Factor strength | Wait | Quality is the strongest factor at 61/100. |
| Timing | Wait | Momentum is 43/100. |
| Regime fit | Wait | XBI is in a Neutral regime at 54/100. |
| Risk control | Wait | Risk factor is 59/100 with beta of 1.10 suggests market-like sensitivity. |
| Conflict | Pass | Current conflict: quality leads at 61/100 while momentum lags at 43/100. |
XBI's recent component-level deltas are not available in this snapshot. Use the current AIQ, Sharpe, and volatility profile above as the primary read until the next data refresh.
Signal snapshot as of 2026-07-28T04:58:53.297Z.
| Metric | Current |
|---|---|
| AIQ Score | 54/100 |
| Price | $152.11 |
| Sharpe Ratio | 1.99 |
| Beta | 1.10 |
XBI vs Sector ETFs Peers
Portfolio Implication
Related Links
XBI Stock FAQ
What does the XBI AIQ Score mean?
AIQ Score summarizes multiple factors for XBI, including momentum, value, quality, and risk. Higher scores generally indicate stronger combined signals, but you should still validate with your own risk tolerance.
How often is XBI data updated?
XBI quote and scoring components refresh on the platform cadence. Always confirm timestamp freshness on-page before making time-sensitive decisions.
Should I compare XBI with an index before investing?
Yes. Comparing XBI versus benchmarks like SPY or QQQ helps you separate stock-specific strength from broader market moves.
Where can I review deeper XBI fundamentals, technicals, and risk?
Use the Fundamentals, Technicals, and Risk tabs from this page to inspect driver-level metrics behind the headline score.
How the AIQ Score Is Built
Methodology, factor weights, and how to interpret score history
Loading XBI...